Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Safety and Tolerability of Etanercept in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE3
A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
- Status
- COMPLETED
- Phase
- NA
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults
- Status
- COMPLETED
- Phase
- NA
Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Semagacestat for Alzheimer's Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE1
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Exelon Patch and Combination With Memantine Comparative Trial
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
- Status
- COMPLETED
- Phase
- NA
Clinical Trial of Donepezil Between the Naive Group and the Switching Group
- Status
- COMPLETED
- Phase
- NA
Genes, Exercise, Memory and Neurodegeneration
- Status
- COMPLETED
- Phase
- NA
Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2